Published in J Virol on November 01, 2002
Recognition of herpesviruses by the innate immune system. Nat Rev Immunol (2011) 1.96
A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. J Exp Med (2005) 1.68
Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol (2003) 1.53
Clearance of herpes simplex virus type 2 by CD8+ T cells requires gamma interferon and either perforin- or Fas-mediated cytolytic mechanisms. J Virol (2005) 1.45
Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J Biol Chem (2008) 1.32
The addition of tumor necrosis factor plus beta interferon induces a novel synergistic antiviral state against poxviruses in primary human fibroblasts. J Virol (2008) 1.32
Tumor necrosis factor (TNF) protects resistant C57BL/6 mice against herpes simplex virus-induced encephalitis independently of signaling via TNF receptor 1 or 2. J Virol (2006) 1.27
Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol (2004) 1.24
Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo. J Virol (2011) 1.18
Lethal encephalitis in myeloid differentiation factor 88-deficient mice infected with herpes simplex virus 1. Am J Pathol (2005) 1.16
Human cancer cells have specifically lost the ability to induce the synergistic state caused by tumor necrosis factor plus interferon-beta. Cytokine (2009) 1.14
Innate and adaptive immune responses to herpes simplex virus. Viruses (2009) 1.14
Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am J Pathol (2010) 1.09
STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J Virol (2008) 1.09
Geldanamycin, a ligand of heat shock protein 90, inhibits the replication of herpes simplex virus type 1 in vitro. Antimicrob Agents Chemother (2004) 1.06
Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J (2005) 1.04
Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J Gen Virol (2005) 1.04
Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol (2005) 1.03
Macrophages and cytokines in the early defence against herpes simplex virus. Virol J (2005) 1.00
Re-evaluating natural resistance to herpes simplex virus type 1. J Virol (2004) 0.99
Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons. J Virol (2007) 0.98
Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts. J Virol (2007) 0.96
Re-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1. Virol J (2005) 0.95
Activation and evasion of innate antiviral immunity by herpes simplex virus. Viruses (2009) 0.94
Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One (2010) 0.92
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea. J Immunol (2007) 0.91
Suppression of herpes simplex virus 1 in MDBK cells via the interferon pathway. J Virol (2004) 0.87
Herpes simplex virus (HSV)-specific T cells activated in the absence of IFN-gamma express alternative effector functions but are not protective against genital HSV-2 infection. J Reprod Immunol (2009) 0.87
TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1. PLoS One (2013) 0.85
The challenge of developing a herpes simplex virus 2 vaccine. Expert Rev Vaccines (2012) 0.85
Herpes simplex virus 1 tropism for human sensory ganglion neurons in the severe combined immunodeficiency mouse model of neuropathogenesis. J Virol (2012) 0.84
Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine (2013) 0.83
Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation. J Virol (2011) 0.83
Rapid clearance of herpes simplex virus type 2 by CD8+ T cells requires high level expression of effector T cell functions. J Reprod Immunol (2011) 0.82
Permissive human cytomegalovirus infection of a first trimester extravillous cytotrophoblast cell line. Virol J (2004) 0.81
Distinctive roles for 2',5'-oligoadenylate synthetases and double-stranded RNA-dependent protein kinase R in the in vivo antiviral effect of an adenoviral vector expressing murine IFN-beta. J Immunol (2004) 0.81
Characterization of a potent refractory state and persistence of herpes simplex virus 1 in cell culture. J Virol (2006) 0.79
hsp70 and a novel axis of type I interferon-dependent antiviral immunity in the measles virus-infected brain. J Virol (2012) 0.78
Bacterial artificial chromosome derived simian varicella virus is pathogenic in vivo. Virol J (2013) 0.78
The synergistic effect of IFN-alpha and IFN-gamma against HSV-2 replication in Vero cells is not interfered by the plant antiviral 1-cinnamoyl-3, 11-dihydroxymeliacarpin. Virol J (2006) 0.78
Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium. J Virol (2015) 0.77
Incorporation of the B18R gene of vaccinia virus into an oncolytic herpes simplex virus improves antitumor activity. Mol Ther (2012) 0.77
Elucidating the host-pathogen interaction between human colorectal cells and invading Enterovirus 71 using transcriptomics profiling. FEBS Open Bio (2014) 0.76
An image-based genetic assay identifies genes in T1D susceptibility loci controlling cellular antiviral immunity in mouse. PLoS One (2014) 0.76
Interferon-gamma, macrophages, and virus spread after HSV-1 injection. Invest Ophthalmol Vis Sci (2011) 0.76
Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication. Sci Rep (2015) 0.75
Abrogation of the interferon response promotes more efficient human cytomegalovirus replication. J Virol (2014) 0.75
Signal transducer and activator of transcription 3 (Stat3) regulates host defense and protects mice against herpes simplex virus-1 (HSV-1) infection. J Leukoc Biol (2016) 0.75
Constitutive IFNα/β signaling maintains expression of signaling intermediaries for efficient cytokine responses. JAKSTAT (2016) 0.75
Immune- and Nonimmune-Compartment-Specific Interferon Responses Are Critical Determinants of Herpes Simplex Virus-Induced Generalized Infections and Acute Liver Failure. J Virol (2016) 0.75
Aurintricarboxylic acid increases yield of HSV-1 vectors. Mol Ther Methods Clin Dev (2014) 0.75
Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen. Cell Rep (2017) 0.75
Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity (1996) 8.27
The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol (1993) 5.88
RELATIONSHIP BETWEEN THE ENVELOPE AND THE INFECTIVITY OF HERPES SIMPLEX VIRUS. Proc Soc Exp Biol Med (1964) 4.78
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med (2000) 4.39
IDU therapy of herpes simplex. Arch Ophthalmol (1962) 4.32
CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med (2000) 3.62
Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest (1997) 3.52
Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A (2000) 3.51
Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med (1995) 3.40
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc Natl Acad Sci U S A (1994) 3.34
Spontaneous molecular reactivation of herpes simplex virus type 1 latency in mice. Proc Natl Acad Sci U S A (2002) 2.94
Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest (1998) 2.85
Effect of acycloguanosine treatment of acute and latent herpes simplex infections in mice. Antimicrob Agents Chemother (1979) 2.75
Gamma interferon expression during acute and latent nervous system infection by herpes simplex virus type 1. J Virol (1995) 2.66
Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol (2000) 2.66
Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med (1992) 2.65
Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J Virol (1996) 2.62
Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J Virol (2001) 2.43
Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol (1996) 2.33
Herpes simplex virus ICP0 and ICP34.5 counteract distinct interferon-induced barriers to virus replication. J Virol (2002) 2.04
Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virology (1994) 2.04
Immune cell infiltration and persistence in the mouse trigeminal ganglion after infection of the cornea with herpes simplex virus type 1. J Neuroimmunol (1995) 1.89
T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J Exp Med (1997) 1.77
Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother (2000) 1.76
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology (2002) 1.76
The second-site mutation in the herpes simplex virus recombinants lacking the gamma134.5 genes precludes shutoff of protein synthesis by blocking the phosphorylation of eIF-2alpha. J Virol (1998) 1.76
ICP0, ICP4, or VP16 expressed from adenovirus vectors induces reactivation of latent herpes simplex virus type 1 in primary cultures of latently infected trigeminal ganglion cells. J Virol (2001) 1.76
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice. J Infect Dis (1999) 1.70
The essential prerequisites for quantitative RT-PCR. Nat Biotechnol (1999) 1.61
Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol (1984) 1.60
Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J Virol (2002) 1.58
Gamma interferon (IFN-gamma) receptor null-mutant mice are more susceptible to herpes simplex virus type 1 infection than IFN-gamma ligand null-mutant mice. J Virol (1999) 1.54
Immune-mediated protection from measles virus-induced central nervous system disease is noncytolytic and gamma interferon dependent. J Virol (2002) 1.51
Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol (1999) 1.46
Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo. J Virol (2000) 1.45
Tipping the scales of herpes simplex virus reactivation: the important responses are local. Nat Med (1998) 1.26
Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1. Virology (1997) 1.24
Herpetic stromal keratitis in the reconstituted scid mouse model. J Virol (1993) 1.21
Role of NK cells in protection of mice against herpes simplex virus-1 infection. J Immunol (1987) 1.14
Oral shedding of herpes simplex virus type 1: a review. J Oral Pathol Med (1997) 1.13
Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. J Virol (1999) 1.11
Synergistic activities of type I (alpha, beta) and type II (gamma) murine interferons. Antiviral Res (1982) 1.07
Immune cell infiltration in corneas of mice with recurrent herpes simplex virus disease. J Gen Virol (1996) 1.06
The inherent quantitative capacity of the reverse transcription-polymerase chain reaction. Anal Biochem (1999) 1.06
In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J Neuroimmunol (1999) 1.06
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J Virol (2000) 1.05
Reoviruses and the interferon system. Curr Top Microbiol Immunol (1998) 1.03
Epidemiology of genital herpes. J Int Med Res (1994) 1.03
Quantitative analysis of polymerase chain reaction products by dot blot. Anal Biochem (1996) 0.98
Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis (1994) 0.97
Enhanced inhibition of herpes simplex virus type 1 growth in human corneal fibroblasts by combinations of interferon-alpha and -gamma. J Infect Dis (1992) 0.96
Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol (1999) 0.95
Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study. Antimicrob Agents Chemother (1998) 0.89
Effect of exogenous interferon on herpetic keratitis in rabbits and monkeys. Invest Ophthalmol (1973) 0.87
Herpesvirus infections in persons infected with human immunodeficiency virus. Clin Infect Dis (1995) 0.85
Interferon as an agent against herpes simplex virus. J Invest Dermatol (1990) 0.84
Expression of human and macaque type I IFN transgenes interferes with HSV-1 replication at the transcriptional and translational levels: IFN-beta is more potent than IFN-alpha 2. Virology (2001) 0.83
Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits. Antimicrob Agents Chemother (2001) 0.81
Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2. Med Microbiol Immunol (1985) 0.80
Development of antiviral therapy with alpha interferons: promises, false hopes and accomplishments. Ann Med (1995) 0.78
The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology (2002) 1.76
Green fluorescent protein is a quantitative reporter of gene expression in individual eukaryotic cells. FASEB J (2005) 1.26
Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells. J Gen Virol (2005) 1.04
The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog (2011) 1.00
Evidence that spontaneous reactivation of herpes virus does not occur in mice. Virol J (2005) 0.95
Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J Virol (2010) 0.94
ICP0 dismantles microtubule networks in herpes simplex virus-infected cells. PLoS One (2010) 0.93
Oligoadenylate synthetase/protein kinase R pathways and alphabeta TCR+ T cells are required for adenovirus vector: IFN-gamma inhibition of herpes simplex virus-1 in cornea. J Immunol (2007) 0.91
Investigation of the mechanism by which herpes simplex virus type 1 LAT sequences modulate preferential establishment of latent infection in mouse trigeminal ganglia. J Virol (2009) 0.89
ICP0 antagonizes ICP4-dependent silencing of the herpes simplex virus ICP0 gene. PLoS One (2010) 0.86
Nuclear double-fluorescent reporter for in vivo and ex vivo analyses of biological transitions in mouse nuclei. Mamm Genome (2013) 0.85
Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways. J Neuroimmunol (2008) 0.83
HSV-1 latent rabbits shed viral DNA into their saliva. Virol J (2012) 0.82
Absence of PKR attenuates the anti-HSV-1 activity of an adenoviral vector expressing murine IFN-beta. J Interferon Cytokine Res (2002) 0.81